triamcinolone acetonide has been researched along with Branch Vein Occlusion in 216 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.46) | 18.2507 |
| 2000's | 119 (55.09) | 29.6817 |
| 2010's | 85 (39.35) | 24.3611 |
| 2020's | 11 (5.09) | 2.80 |
| Authors | Studies |
|---|---|
| Barry, S; Court, M; Elkeeb, A | 1 |
| Bhikoo, R; Chen, FK; Kanagalingam, E; McAllister, IL; McLenachan, S; Vijayasekaran, S; Yu, DY; Zhang, D | 1 |
| Alhalabi, NM; Ali, BM; Azmeh, AM | 1 |
| Dikmetas, O; Gelisken, F; Kuehlewein, L | 1 |
| Eah, KS; Kim, JG; Kim, YJ; Kim, YN; Lee, JY; Park, YJ; Yoon, YH | 1 |
| Koyama, Y; Miyoshi, Y; Muraoka, Y; Nakano, Y; Osaka, R; Suzuma, K; Takasago, Y; Tsujikawa, A | 1 |
| Fazal, R; Mohan, R | 1 |
| Baba, T; Oshitari, T; Takatsuna, Y; Tatsumi, T; Yamamoto, S | 1 |
| Bosnar, D; De Salvo, G; Matić, S; Tedeschi Reiner, E; Vinković, M | 1 |
| Cunefare, D; Danis, RP; Farsiu, S; Noronha, G; Vuong, VS; Willoughby, AS; Yiu, G | 2 |
| Fine, HF; Grossniklaus, HE; Prenner, JL; Reshef, ER; Roth, DB; Shah, SP | 1 |
| Saxena, H; Sharma, B; Sinha, P; Takkar, B | 1 |
| Fekrat, S; Khan, K; Rothman, AL; Thomas, AS | 1 |
| Borkar, D; Goodman, J; Obeid, A; Pancholy, M; Regillo, C; Storey, PP; Su, D | 1 |
| Abdullatif, AM; Fouad, HM; Helmy, YAH; Macky, TA; Mansour, K; Saady, AM | 1 |
| Kawano, H; Nakamura, M; Otsuka, H; Sakamoto, T; Sonoda, S | 1 |
| Ober, MD; Valijan, S | 1 |
| Acar, Z; Demir, M; Dirim, B; Oba, E; Sendul, Y | 1 |
| Han, DH; Lee, DY; Nam, DH; Sohn, HJ | 1 |
| Jin, ZY; Jonas, JB; Tao, Y; Wong, IY; Zhu, D | 1 |
| Durukan, AH; Erdurman, FC; Gokce, G; Sobaci, G | 1 |
| Ali, RI; Gibran, SK; Kapoor, KG; Khan, AN | 1 |
| Figueroa, MS; Ruiz Moreno, JM | 1 |
| Boscia, F; Ciracì, L; Dayani, P; Flynn, HW; Furino, C; Mariotti, C; Sborgia, A; Tabandeh, H | 1 |
| Dehsarvi, B; Entezari, M; Esfandiari, H; Moradian, S; Ramezani, A; Soheilian, M; Yaseri, M | 2 |
| Jo, YJ; Kang, SW; Kim, HK; Kim, JG; Lee, DH; Lee, JY; Park, KH; Yoon, HS; Yoon, YH | 1 |
| Jung, H; Lee, K; Sohn, J | 1 |
| Acar, Z; Cinar, S; Demir, M; Guven, D; Oba, E | 1 |
| Fan, C; Ji, Q; Wang, Y; Xie, J; Zhao, B | 1 |
| Alshareef, RA; Garg, SJ; Hsu, J; Park, C; Spirn, MJ; Vander, J | 1 |
| Bullejos Molina, M; Cordovés Dorta, L; Losada Castillo, MJ; Lozano López, V; Mantolán Sarmiento, C; Pareja Ríos, A; Quijada Fumero, E; Serrano García, M; Virgós Aller, T | 1 |
| Hasegawa, T; Masuda, N; Ogata, N | 1 |
| Kim, CG; Kim, JH; Kim, JW; Lee, TG; Yoo, SG | 1 |
| Heroman, JW; Ozkok, A; Saleh, OA; Schaal, S; Sigford, DK | 1 |
| Aref, AA; Blodi, BA; Ip, MS; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
| Sharma, A | 1 |
| Ozkok, A; Schaal, S | 1 |
| Erdol, H; Hacioglu, D; Kola, M; Turk, A | 1 |
| Ho, M; Jonas, JB; Lam, DS; Liu, DT | 1 |
| Dikel, NH; Ornek, K; Yumusak, E | 1 |
| Dhawan, A; Shukla, D | 1 |
| An, N; Ha, W; Hu, X; Ma, A; Zhang, S; Zhao, B | 1 |
| Agarwal, R; Arora, R; Ghosh, B; Goyal, JL; Jain, P | 1 |
| Kim, M; Moon, J; Sagong, M | 1 |
| Hirano, Y; Nishiyama, T; Ogura, Y; Suzuki, N; Tomiyasu, T; Uemura, A; Yasukawa, T; Yoshida, M | 1 |
| Chhablani, J; Dolz-Marco, R; Gallego-Pinazo, R; Paulose, R; Stewart, M | 1 |
| Song, H; Wang, L | 1 |
| Cheng, KC; Lin, CJ; Wu, WC | 1 |
| Stoffelns, BM | 1 |
| Iacono, P; Parodi, MB; Ravalico, G | 1 |
| Byeon, SH; Park, YS | 1 |
| Hernaez-Ortega, MC; Soto-Pedre, E | 2 |
| Durmaz, S; Kandemir, N; Kocabora, MS | 1 |
| Breusegem, C; Stalmans, I; Van Calster, J; Vandewalle, E; Zeyen, T | 1 |
| Angulo Bocco, MC; Coscas, G; Glacet-Bernard, A; Soubrane, G; Zourdani, A | 1 |
| Blodi, BA; Figueroa, M; Ip, MS; Jumper, JM; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
| Chen, SD; McAllister, IL; Vijayasekaran, S; Yu, DY | 1 |
| Cheng, KC; Wu, HJ; Wu, WC | 1 |
| Fish, GE | 1 |
| Ahn, JK; Park, SP | 1 |
| Blodi, BA; Chan, CK; Gonzalez, V; Ip, MS; Oden, NL; Scott, IU; Vanveldhuisen, PC | 1 |
| Bakri, SJ; Edwards, AO; Pulido, JS; Risco, M | 1 |
| Fujiwara, T; Hashizume, K; Kurosaka, D; Machida, S; Nabeshima, T | 1 |
| Hirasawa, M; Ishida, S; Noda, K; Ozawa, Y; Shinoda, H; Tsubota, K | 1 |
| Jonas, JB; Libondi, T; Schlichtenbrede, F; Schmidbauer, M | 1 |
| Antoszyk, A; Blodi, BA; Elman, M; Figueroa, M; Ip, MS; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
| Antoszyk, AN; Blodi, BA; Ip, MS; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
| Hou, J; Jiang, YR; Jonas, JB; Li, XX; Tao, Y | 1 |
| Guthoff, R; Hennemann, K; Meigen, T; Schrader, W | 2 |
| Apte, RS | 1 |
| Blodi, BA; Chan, CK; Fisher, M; Gonzalez, VH; Ip, MS; Oden, NL; Scott, IU; Singerman, LJ; Tolentino, M; VanVeldhuisen, PC | 2 |
| Kiernan, DF; Mieler, WF | 1 |
| Chen, KJ; Cheng, KC; Wu, WC | 1 |
| Cohen, SY; Nghiem-Buffet, S | 1 |
| Ciulla, TA; Ehrlich, R; Harris, A; Moss, AM | 1 |
| Blodi, BA; Domalpally, A; Ip, MS; Lauer, AK; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
| Gao, L; Hou, J; Jiang, YR; Li, XX; Tao, Y | 1 |
| Kim, JY; Park, SP | 1 |
| Byun, YJ; Koh, HJ; Lee, SC; Roh, MI | 1 |
| Keating, D; Muqit, MM; Murdoch, JR; Saidkasimova, S | 1 |
| Bhargava, A; Gupta, C; Sharma, B; Shroff, C; Shroff, D | 1 |
| Hu, YJ | 1 |
| Ciulla, TA; Ehrlich, R; Harris, A; Moss, A | 1 |
| Ishibashi, T; Kunikata, H; Nakazawa, T; Nishida, K; Shimura, M; Sonoda, KH; Yoshimura, T | 1 |
| Kamei, M; Matsumura, N; Nishida, K; Sakaguchi, H; Sayanagi, K; Tano, Y; Tsujikawa, M; Yamamoto, T | 1 |
| Wong, IY | 1 |
| Ackermann, H; Al-Sarireh, F; Koch, FH; Koss, MJ; Naser, H; Sener, A; Singh, P | 1 |
| Cringle, SJ; McAllister, IL; McMenamin, PG; Mendis, KR; Morgan, WH; Vijayasekaran, S; Yu, DY | 1 |
| Chen, HS; Chuang, LH; Ku, WC; Lai, CC; Wang, NK; Yeung, L | 1 |
| Karacorlu, M; Karacorlu, SA; Ozdemir, H; Senturk, F; Uysal, O | 1 |
| Chang, S; Del Priore, LV; Fine, HF; Gelman, SK; Hwang, JC | 1 |
| Altaweel, MM; Blodi, BA; Domalpally, A; Elledge, J; Ip, MS; Kim, JE; Oden, NL; Scott, IU; Van Veldhuisen, PC; Warren, K | 1 |
| Agostini, H; Bertram, B; Feltgen, N; Hansen, L; Hoerauf, H; Jaissle, GB; Pielen, A; Stahl, A | 1 |
| Alagöz, N; Bozkurt, E; Cakır, M; Cekiç, O; Faruk Yılmaz, O; Yazıcı, AT | 1 |
| Blodi, BA; Cohen, G; Hartnett, ME; Ip, MS; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
| Aref, AA; Scott, IU | 2 |
| Chung, H; Kim, HC; Shin, HJ | 1 |
| Ehlers, JP; Fekrat, S | 1 |
| Ding, X; Hu, X; Li, J; Pan, J; Tang, S; Yu, S | 1 |
| Fung, AE; Hung, D; Lim, JI; Wieland, M; Wong, V | 1 |
| Bringmann, A; Drechsler, F; Hollborn, M; Köferl, P; Kohen, L; Rehak, M; Wiedemann, P | 1 |
| Bourcier, T; Gaucher, D; Letsch, J; Saleh, M; Speeg-Schatz, C | 1 |
| Augustin, A; Augustin, C; Barca, F; Bartolo, ED; Cresti, F; Ebert, FG; Rizzo, S | 1 |
| Heussen, FM; Huber, KK; Joussen, AM; Lux, A; Maier, AK; Scholz, C; Winterhalter, S | 1 |
| Grabska-Liberek, I; Jamrozy-Witkowska, A; Jankowska-Lech, I; Kowalska, K; Nowosielska, A; Terelak-Borys, B | 1 |
| Higashiyama, T; Kakinoki, M; Kawamura, H; Ohji, M; Sawada, O; Sawada, T | 1 |
| Funatsu, H; Mimura, T; Noma, H; Shimada, K | 3 |
| Kamei, M; Nishida, K; Suzuki, M; Yano, S | 1 |
| Cheung, CS; Devenyi, RG; Kertes, PJ; Lam, WC; Lui, A; Wong, AW | 1 |
| Duncombe, A; Genevois, O; Le Moigne, O; Muraine, M; Portmann, A | 1 |
| Aggermann, T; Binder, S; Brannath, W; Brunner, S; Haas, P; Krebs, I; Womastek, I | 1 |
| Blodi, BA; Ip, MS; Scott, IU; VanVeldhuisen, PC; Wahle, AE; Weinberg, DV | 1 |
| Bi, C; Chen, F; Wang, H; Wei, Y; Yang, X; Zu, Z | 1 |
| Funatsu, H; Mimura, T; Noma, H | 1 |
| Nentwich, MM; Ulbig, MW | 1 |
| Chen, FH; Wang, HZ; Wang, RS; Wei, Y; Yang, XG | 1 |
| Blodi, BA; Doft, BH; Domalpally, A; Elman, MJ; Ip, MS; Oden, NL; Scott, IU; Vanveldhuisen, PC | 1 |
| Atili, A; Baraki, H; Feltgen, N; Geck, U; Hoerauf, H; Pustolla, N | 1 |
| Ip, MS; Kumar, KS | 1 |
| Degenring, RF; Jonas, JB; Kreissig, I | 1 |
| Bynoe, LA; Weiss, JN | 1 |
| Degenring, RF; Jonas, JB; Kamppeter, B; Kreissig, I | 3 |
| Chaudhry, NA; Chieh, J; Green, SN; Roth, DB; Spirn, MJ; Yarian, DL | 1 |
| Fekrat, S; Jaffe, GJ; Park, CH | 1 |
| Altaweel, M; Ip, M; Kahana, A | 1 |
| Chen, SD; Frith, P; Lochhead, J; Patel, CK | 1 |
| Jonas, JB | 1 |
| Kwong, YY; Lai, WW; Lam, DS | 1 |
| Enaida, H; Ishibashi, T; Kubota, T; Miyazaki, M; Nakamura, T; Noda, Y; Sakamoto, T; Sonoda, KH; Ueno, A; Yokoyama, M | 1 |
| Dogra, MR; Gupta, A; Gupta, V; Kaushik, S; Singh, R | 1 |
| Egbert, P; Engelman, CJ; Palmer, JD | 1 |
| Karacorlu, M; Karacorlu, S; Ozdemir, H | 1 |
| Yamamoto, T | 1 |
| Akkoyun, I; Degenring, RF; Jonas, JB; Kamppeter, B; Kreissig, I | 1 |
| Altaweel, MM; Blodi, BA; Gangnon, RE; Gottlieb, JL; Ip, MS; Kahana, A; Puliafito, CA; Scott, IU | 1 |
| Allam, S; Bashshur, ZF; Haddad, RS; Jurdi, FA; Ma'luf, RN; Noureddin, BN | 1 |
| Bakri, SJ; Beer, PM; Falk, NS; Shah, A | 1 |
| Asano, Y; Hida, T; Hirakata, A; Kojima, E; Morimura, Y; Okada, AA; Wakabayashi, T | 1 |
| Flynn, HW; Scott, IU | 1 |
| Ergun, E; Krepler, K; Richter-Müksch, S; Sacu, S; Stur, M; Wagner, J; Wedrich, A | 2 |
| Dogan, H; Erkilic, K; Evereklioglu, C; Ozkiris, A | 1 |
| O'Donnell, A; Williamson, TH | 1 |
| Eandi, CM; Freund, KB; Klais, CM; Yannuzzi, LA | 1 |
| Klais, CM; Spaide, RF | 1 |
| Hayashi, H; Hayashi, K | 1 |
| Kaiser, PK | 1 |
| Wilkins, M | 1 |
| Awai, N; Fukushima, M; Hirata, A; Inomata, Y; Kawaji, T; Takano, A; Tanihara, H | 1 |
| Avitabile, T; Longo, A; Reibaldi, A | 1 |
| Hung, PT; Lin, JM; Tsai, YY | 1 |
| Ugarte, M; Williamson, TH | 1 |
| Prasad, AG; Shah, GK | 1 |
| Harder, B; Jonas, JB; Kreissig, I; Spandau, UH | 1 |
| Aggermann, T; Binder, S; Brunner, S; Stolba, U | 1 |
| Borkowski, LM; Kurz, DE; Opremcak, EM; Rehmar, AJ; Ridenour, CD | 1 |
| Chen, SD; Lochhead, J; Patel, CK; Sundaram, V | 1 |
| Ho, TC; Lai, WW; Lam, DS | 1 |
| Muftuoglu, G; Sarici, A | 1 |
| Huang, SY; Hung, PT; Lin, JM; Tsai, YY | 1 |
| Hisatomi, T; Kubota, T; Okabe, H; Sakamoto, T; Tawara, A; Yamakiri, K | 1 |
| Gelston, CD; Mandava, N; Olson, JL | 1 |
| Entezari, M; Kadkhodaei, S; Moradian, S; Ramezani, A; Tabatabaei, H | 1 |
| Pathai, S | 1 |
| Erdinç, A; Ozdek, SC | 1 |
| Bencić, G; Konjević Pernar, S; Mandić, Z; Pentz, A; Vatavuk, Z | 1 |
| Cheng, KC; Wu, WC | 1 |
| Ozkiriş, A | 1 |
| Karia, N; Patel, PJ; Zaheer, I | 1 |
| González Barcia, M; Lorenzo Carrero, J; Pérez Flores, I | 1 |
| Bobbili, RB; Mathai, A | 1 |
| Er, H | 1 |
| Berrocal, AM; Flynn, HW; Gregori, G; Gregori, NZ; Lee, JE; Mavrofrides, EC; Murray, TG; Puliafito, CA; Rosenfeld, PJ; Scott, IU; Smiddy, WE | 1 |
| Ai, E; Fu, AD; Goff, MJ; Johnson, RN; Jumper, JM; McDonald, HR; Yang, SS | 1 |
| Lightman, S; McCluskey, P; Sivaprasad, S | 1 |
| Atta, HR; Cauchi, PA; Sarros, M | 1 |
| Ho, TC | 1 |
| Apostolopoulos, M; Brouzas, D; Loukianou, E; Moschos, M; Moschos, MM | 1 |
| Quan, Y; Sun, N; Wang, X; Xiong, Q; Zheng, Y | 1 |
| Chen, C; Du, L; Xing, Y | 1 |
| Gunnarsdóttir, SG; Gunnlaugsdóttir, E; Oehman, DO; Stefánsson, E | 1 |
| Kita, M; Miyamoto, K; Tsujikawa, A; Yamaike, N; Yoshimura, N | 1 |
| Chiu, YT; Hung, PT; Lin, JM; Tsai, YY | 1 |
| Ataka, S; Kurita, K; Shiraki, K; Tayeya, K; Wada, S | 1 |
| Chu, YK; Chung, EJ; Koh, HJ; Kwon, OW; Lee, JH | 1 |
| Ahn, JK; Chung, H; Heo, JW; Oh, JY; Seo, JH | 1 |
| Kita, H; Sakamoto, T; Uemura, A; Yamashita, T | 1 |
| Inatani, M; Iwao, K; Kawaji, T; Koga, T; Mawatari, Y; Tanihara, H | 1 |
| Altintaş, O; Bardak, Y; Cekiç, O; Demirkol, A; Ekim, MM; Oyar, O; Tiğ, SU; Yeşildağ, A | 1 |
| Hirano, Y; Ogura, Y; Sakurai, E; Yoshida, M | 1 |
| Stefánsson, E | 1 |
| Kociecki, J; Lubczyńska, A | 1 |
| Al-Dhibi, H; Al-Saati, A; Chaudhry, IA; Shamsi, FA | 1 |
| Fukushima, M; Inatani, M; Inomata, Y; Iwao, K; Kawaji, T; Sagara, N; Takano, A; Tanihara, H | 1 |
| Asano, S; Miyake, K; Miyake, S; Ota, I | 1 |
| Jonas, JB; Rensch, F | 1 |
| Akmese, E; Batioglu, F; Ozmert, E | 1 |
| Deren, YT; Gurelik, G; Hasanreisoglu, B; Ozdek, S | 1 |
| Karacorlu, M; Karacorlu, SA; Ozdemir, H; Senturk, F | 1 |
| Acar, N; Altan, T; Bayraktar, S; Bayraktar, Z; Cakir, M; Dogan, M; Kapran, Z; Yilmaz, OF | 1 |
| Allingham, RR; Fekrat, S; Im, L; Singh, I; Stinnett, S | 1 |
| Ahn, JK; Lee, GH; Park, YG | 1 |
| Chung, EJ; Koh, HJ; Lee, H | 1 |
| Bingaman, DP; Danis, RP; Ladd, B; Yang, Y | 1 |
| Hayler, JK; Jonas, JB; Panda-Jonas, S; Söfker, A | 1 |
| Duker, JS; Greenberg, PB; Martidis, A; Reichel, E; Rogers, AH | 1 |
13 review(s) available for triamcinolone acetonide and Branch Vein Occlusion
| Article | Year |
|---|---|
Meta-analysis of the effect of intravitreal bevacizumab versus intravitreal triamcinolone acetonide in central retinal vein occlusion.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Retinal Vein Occlusion; Time Factors; Triamcinolone Acetonide; Visual Acuity | 2013 |
[BRAVO and CRUISE: ranibizumab for the treatment of macular edema secondary to retinal vein occlusion].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Biomarkers; Clinical Trials, Phase III as Topic; Dexamethasone; Drug Implants; Follow-Up Studies; Humans; Intravitreal Injections; Laser Coagulation; Macula Lutea; Macular Edema; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ranibizumab; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2012 |
RETINAL VEIN OCCLUSIONS, FROM BASICS TO THE LATEST TREATMENT.
Topics: Angiogenesis Inhibitors; Bevacizumab; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Vein Occlusion; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2016 |
The use of intraocular corticosteroids.
Topics: Animals; Anti-Inflammatory Agents; Clinical Trials as Topic; Drug Implants; Glucocorticoids; Humans; Injections; Macular Degeneration; Retinal Vein Occlusion; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2009 |
[Retinal vein occlusion: anti-VEGF treatments].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Blood-Retinal Barrier; Clinical Trials as Topic; Humans; Macular Edema; Prospective Studies; Ranibizumab; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2009 |
Combination therapy in diabetic macular oedema and retinal vein occlusion--past and present.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Clinical Trials as Topic; Diabetic Retinopathy; Drug Therapy, Combination; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy | 2012 |
[Intravitreal drug therapy for retinal vein occlusion--pathophysiological mechanisms and routinely used drugs].
Topics: Adrenal Cortex Hormones; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Blood Flow Velocity; Cell Division; Combined Modality Therapy; Dexamethasone; Endothelium, Vascular; Erythropoietin; Hemodilution; Humans; Intravitreal Injections; Laser Coagulation; Long-Term Care; Papilledema; Prognosis; Randomized Controlled Trials as Topic; Ranibizumab; Retinal Artery; Retinal Vein; Retinal Vein Occlusion; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2010 |
Management of macular edema secondary to branch retinal vein occlusion: an evidence-based update.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dexamethasone; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Prostheses and Implants; Ranibizumab; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitrectomy | 2011 |
Management of macular edema secondary to central retinal vein occlusion: an evidence-based.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dexamethasone; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Prostheses and Implants; Ranibizumab; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitrectomy | 2011 |
The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy.
Topics: Adrenal Cortex Hormones; Biological Availability; Delayed-Action Preparations; Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Humans; Intravitreal Injections; Macular Degeneration; Macular Edema; Posterior Eye Segment; Retinal Vein Occlusion; Triamcinolone Acetonide; Uveitis, Posterior | 2012 |
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Combined Modality Therapy; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris Diseases; Macular Degeneration; Macular Edema; Ocular Hypotension; Ophthalmia, Sympathetic; Papilledema; Photochemotherapy; Retinal Diseases; Retinal Neovascularization; Retinal Vein Occlusion; Time Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2004 |
[The management for macular edema].
Topics: Adrenal Cortex Hormones; Capillary Permeability; Cytokines; Decompression, Surgical; Drug Design; Humans; Macular Edema; Ophthalmologic Surgical Procedures; Prostaglandins; Retinal Artery; Retinal Vein; Retinal Vein Occlusion; Tissue Plasminogen Activator; Triamcinolone Acetonide; Vitrectomy | 2004 |
Intravitreal steroids in the management of macular oedema.
Topics: Dexamethasone; Fluocinolone Acetonide; Glucocorticoids; Humans; Inflammation; Injections; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
41 trial(s) available for triamcinolone acetonide and Branch Vein Occlusion
| Article | Year |
|---|---|
COMBINED TREATMENT WITH BEVACIZUMAB AND TRIAMCINOLONE ACETONIDE FOR MACULAR EDEMA DUE TO RETINAL VEIN OCCLUSION.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Glucocorticoids; Humans; Macular Edema; Prospective Studies; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2020 |
Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion.
Topics: Adult; Aged; Aged, 80 and over; Choroid; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2018 |
The value of prednisolone acetate provocative test before intravitreal triamcinolone acetonide injections.
Topics: Administration, Ophthalmic; Adult; Aged; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prednisolone; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide | 2020 |
Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusion.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2014 |
Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aqueous Humor; Bevacizumab; Cytokines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retina; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent onset central retinal vein occlusion.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Retina; Retinal Vein Occlusion; Single-Blind Method; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Comparison of injection of intravitreal drugs with standard care in macular edema secondary to branch retinal vein occlusion.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Therapy; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Case-Control Studies; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Ranibizumab; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2014 |
Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Risk Factors; Time Factors; Tonometry, Ocular; Triamcinolone Acetonide | 2015 |
The effectiveness and reliability of posterior sub-Tenon triamcinolone acetonide injection in branch retinal vein occlusion-related macular edema.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Eye; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2016 |
Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular oedema in branch retinal vein occlusion: a pilot study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Male; Middle Aged; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity | 2008 |
SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type.
Topics: Aged; Aged, 80 and over; Glucocorticoids; Humans; Injections; Observer Variation; Photography; Reproducibility of Results; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
SCORE Study report 3: study design and baseline characteristics.
Topics: Aged; Aged, 80 and over; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Research Design; Retina; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.
Topics: Blindness; Equipment Design; Eye Foreign Bodies; Glucocorticoids; Humans; Incidence; Injections; Macular Edema; Prospective Studies; Retinal Vein Occlusion; Silicone Oils; Syringes; Triamcinolone Acetonide; Vitreous Body | 2009 |
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlus
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Observation; Prospective Studies; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2009 |
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlu
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body; Young Adult | 2009 |
The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4.
Topics: Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Prospective Studies; Quality Control; Reproducibility of Results; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2009 |
Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9.
Topics: Aged; Aged, 80 and over; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Observer Variation; Photography; Quality Control; Reproducibility of Results; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2010 |
A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Combinations; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macula Lutea; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.
Topics: Anthropometry; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Prognosis; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2011 |
Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Young Adult | 2011 |
Sustained-release intravitreal liquid drug delivery using triamcinolone acetonide for cystoid macular edema in retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Cohort Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluocinolone Acetonide; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2011 |
Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |
Functional-morphological changes after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion.
Topics: Aged; Female; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity | 2012 |
Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent-onset branch retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macula Lutea; Male; Middle Aged; Retinal Vein Occlusion; Retreatment; Single-Blind Method; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
A prospective, randomised, multicenter trial for surgical treatment of central retinal vein occlusion: results of the Radial Optic Neurotomy for Central Vein Occlusion (ROVO) study group.
Topics: Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Male; Ophthalmologic Surgical Procedures; Optic Nerve; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2013 |
Score Study Report 12: Development of venous collaterals in the Score Study.
Topics: Collateral Circulation; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Optic Disk; Retinal Vein; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2013 |
Baseline characteristics and response to treatment of participants with hemiretinal compared with branch retinal or central retinal vein occlusion in the standard care vs corticosteroid for retinal vein occlusion (SCORE) study: SCORE study report 14.
Topics: Female; Glucocorticoids; Humans; Intravitreal Injections; Male; Randomized Controlled Trials as Topic; Retinal Vein; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2012 |
Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide.
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Injections; Intraocular Pressure; Ischemia; Male; Prospective Studies; Retinal Vein; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
Topics: Aged; Chronic Disease; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Therapy; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Orbit; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Topics: Aged; Combined Modality Therapy; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Retinal Artery Occlusion; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris; Male; Middle Aged; Neovascularization, Pathologic; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.
Topics: Aged; Cataract; Diabetic Retinopathy; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Early versus late intravitreal triamcinolone acetonide for macular edema associated with branch retinal vein occlusion.
Topics: Drug Administration Schedule; Female; Fovea Centralis; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2007 |
Relationship between blood-aqueous barrier disruption and ischemic macular edema in patients with branch or central retinal vein occlusion: effects of sub-tenon triamcinolone acetonide injection.
Topics: Aged; Aged, 80 and over; Blood-Aqueous Barrier; Female; Follow-Up Studies; Humans; Injections; Intraocular Pressure; Ischemia; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2007 |
Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.
Topics: Aged; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retinal Detachment; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion.
Topics: Adult; Aged; Connective Tissue; Decompression, Surgical; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Retinal Vessels; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone.
Topics: Aged; Aged, 80 and over; Crystallization; Diabetic Retinopathy; Female; Glaucoma, Neovascular; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris; Male; Middle Aged; Neovascularization, Pathologic; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2001 |
162 other study(ies) available for triamcinolone acetonide and Branch Vein Occlusion
| Article | Year |
|---|---|
Retinal and Choroidal Vascular Occlusion after Intranasal Triamcinolone Injection.
Topics: Choroid; Glucocorticoids; Humans; Retina; Retinal Vein Occlusion; Triamcinolone; Triamcinolone Acetonide | 2022 |
Inner Retinal Changes in Acute Experimental BRVO Treated With Bevacizumab or Triamcinolone Acetonide.
Topics: Animals; Bevacizumab; Retina; Retinal Vein Occlusion; Swine; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2023 |
Suprachoroidal triamcinolone acetonide for the treatment of macular edema associated with retinal vein occlusion: a pilot study.
Topics: Glaucoma; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Pilot Projects; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2023 |
Rebound Phenomenon after Intravitreal Injection of Triamcinolone Acetonide for Macular Edema.
Topics: Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2020 |
CENTRAL RETINAL VEIN OCCLUSION IN YOUNG PATIENTS: Clinical Characteristics and Prognostic Factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Prognosis; Receptors, Vascular Endothelial Growth Factor; Republic of Korea; Retinal Vein Occlusion; Retinal Vessels; Retrospective Studies; Risk Assessment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Young Adult | 2021 |
One-year results of anti-vascular endothelial growth factor therapy combined with triamcinolone acetonide for macular edema associated with branch retinal vein occlusion.
Topics: Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2020 |
Periocular steroids for macular edema associated with retinal arteriovenous malformation: A case report.
Topics: Adult; Angiogenesis Inhibitors; Arteriovenous Malformations; Bevacizumab; Glucocorticoids; Hemangioma; Humans; Macular Edema; Male; Neoplasm Recurrence, Local; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide | 2020 |
Effects of Switching from Anti-VEGF Treatment to Triamcinolone Acetonide in Eyes with Refractory Macular Edema Associated with Diabetic Retinopathy or Retinal Vein Occlusion.
Topics: Aged; Cytokines; Diabetic Retinopathy; Eye; Female; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2020 |
CLINICAL FINDINGS IN TRIAMCINOLONE-ASSOCIATED MACULOPATHY.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Crystallization; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Microscopy, Electron, Transmission; Middle Aged; Retina; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide | 2019 |
Choroidal Changes After Suprachoroidal Injection of Triamcinolone in Eyes With Macular Edema Secondary to Retinal Vein Occlusion.
Topics: Choroid; Humans; Injections; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide | 2018 |
Reply.
Topics: Choroid; Humans; Injections; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide | 2018 |
CENTRAL RETINAL VEIN OCCLUSION IN YOUNG INDIVIDUALS: A Comparison of Risk Factors and Clinical Outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Receptors, Vascular Endothelial Growth Factor; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Young Adult | 2019 |
OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Tonometry, Ocular; Triamcinolone Acetonide; Uveitis, Posterior | 2020 |
Particle-induced endophthalmitis: possible mechanisms of sterile endophthalmitis after intravitreal triamcinolone.
Topics: Aqueous Humor; Cells, Cultured; Cytokines; Diabetic Retinopathy; Endophthalmitis; Epithelial Cells; Glucocorticoids; Granulocytes; Granuloma, Foreign-Body; Humans; Intravitreal Injections; Lens, Crystalline; Macular Degeneration; Retinal Pigment Epithelium; Retinal Vein Occlusion; Triamcinolone Acetonide | 2013 |
The duration of effect of centrifuge concentrated intravitreal triamcinolone acetonide.
Topics: Biological Availability; Centrifugation; Diabetic Retinopathy; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retinal Vasculitis; Retinal Vein Occlusion; Retrospective Studies; Time Factors; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2013 |
Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract; Female; Glaucoma; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Turkey; Vascular Endothelial Growth Factor A; Visual Acuity; Young Adult | 2013 |
Efficacy of combined intravitreal bevacizumab and triamcinolone for branch retinal vein occlusion.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting.
Topics: Ambulatory Surgical Procedures; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Endophthalmitis; Glucocorticoids; Humans; Incidence; Intravitreal Injections; Macular Edema; Operating Rooms; Ranibizumab; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Wet Macular Degeneration | 2014 |
Improved visual outcome with early treatment in macular edema secondary to retinal vein occlusions: 6-month results of a Korean RVO study.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Secondary Prevention; Time Factors; Triamcinolone Acetonide; Visual Acuity | 2014 |
Results of intravitreal triamcinolone acetonide in patients with macular edema secondary to branch retinal vein occlusion.
Topics: Aged; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2014 |
Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity | 2014 |
[A cost-effectiveness study of dexamethasone implants in macular edema].
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Cataract; Cost-Benefit Analysis; Dexamethasone; Diabetic Retinopathy; Drug Implants; Female; Humans; Macular Edema; Male; Middle Aged; Off-Label Use; Recurrence; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Posterior; Visual Acuity; Vitrectomy; Vitreous Body | 2015 |
Highly reflective line in optical coherence tomography images of eyes with macular edema associated with branch retinal vein occlusion.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Biomarkers; Cross-Sectional Studies; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Photoreceptor Cells, Vertebrate; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2015 |
THE OMAR STUDY: Comparison of Ozurdex and Triamcinolone Acetonide for Refractory Cystoid Macular Edema in Retinal Vein Occlusion.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Drug Combinations; Drug Costs; Drug Implants; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Correspondence.
Topics: Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Female; Glucocorticoids; Humans; Macular Edema; Male; Retinal Vein Occlusion; Triamcinolone Acetonide | 2015 |
Reply: To PMID 25748280.
Topics: Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Female; Glucocorticoids; Humans; Macular Edema; Male; Retinal Vein Occlusion; Triamcinolone Acetonide | 2015 |
Comparison of choroidal thickness changes following intravitreal dexamethasone, ranibizumab, and triamcinolone in eyes with retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid; Dexamethasone; Drug Implants; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Ranibizumab; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2016 |
Combined occlusion of branch retinal artery and vein secondary to prepapillary arterial loops.
Topics: Combined Modality Therapy; Eye Abnormalities; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Optic Disk; Retinal Artery; Retinal Artery Occlusion; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders | 2015 |
Factors correlated with the resolution of macular oedema after one dose injection of intravitreal triamcinolone acetonide treatment in branch retinal vein occlusion.
Topics: Demography; Dose-Response Relationship, Drug; Female; Humans; Intravitreal Injections; Light Coagulation; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide | 2016 |
Evaluation of pattern electroretinogram in retinal vein occlusion treated with intravitreal triamcinolone acetonide.
Topics: Adult; Aged; Contrast Sensitivity; Electroretinography; Female; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2016 |
Microaneurysms cause refractory macular edema in branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Combined Modality Therapy; Female; Humans; Intravitreal Injections; Light Coagulation; Macular Edema; Male; Microaneurysm; Ranibizumab; Regression Analysis; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vitrectomy | 2016 |
Clinical Characteristics and Treatment Outcomes of Recurrent Central Retinal Vein Occlusions.
Topics: Adult; Aged; Angiogenesis Inhibitors; Bevacizumab; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Incidence; India; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Receptors, Vascular Endothelial Growth Factor; Recurrence; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2018 |
Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion.
Topics: Adult; Aged; Drug Administration Schedule; Eyeglasses; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Intravitreal triamcinolone acetonide for patients with macular oedema due to central retinal vein occlusion in Taiwan.
Topics: Adult; Aged; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Taiwan; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2009 |
[Central Retinal Vein Occlusion accompanied by positive testing of serum antineutrophil cytoplasmic antibodies (c-ANCA)].
Topics: Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Aspirin; Combined Modality Therapy; Fluorescein Angiography; Granulomatosis with Polyangiitis; Hemodilution; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Vasculitis; Vision Disorders; Vitreous Body | 2008 |
Cytomegalovirus retinitis after intravitreous triamcinolone injection in a patient with central retinal vein occlusion.
Topics: Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; DNA, Viral; Female; Ganciclovir; Humans; Immunosuppressive Agents; Injections; Macular Edema; Polymerase Chain Reaction; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2008 |
Intravitreal injection of triamcinolone acetonide and intraocular pressure.
Topics: Balloon Occlusion; Equipment Design; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Monitoring, Intraoperative; Retinal Vein Occlusion; Tonometry, Ocular; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2008 |
Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection.
Topics: Choroid Diseases; Disease Progression; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Recurrence; Retinal Detachment; Retinal Diseases; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2008 |
Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Confidence Intervals; Dexamethasone; Diabetic Retinopathy; Diagnostic Techniques, Ophthalmological; False Positive Reactions; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Predictive Value of Tests; Prospective Studies; Retinal Vein Occlusion; Sensitivity and Specificity; Telangiectasis; Triamcinolone Acetonide | 2009 |
[Intravitreous injection: retrospective study on 2028 injections and their side effects].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Cataract; Diabetic Retinopathy; Endophthalmitis; Epiretinal Membrane; Humans; Injections; Macular Degeneration; Macular Edema; Ocular Hypertension; Ranibizumab; Retinal Detachment; Retinal Perforations; Retinal Vein Occlusion; Retrospective Studies; Risk Assessment; Triamcinolone Acetonide; Vitreous Body; Vitreous Hemorrhage | 2008 |
Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.
Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Disease Models, Animal; Down-Regulation; Fluorescein Angiography; Fluorescent Antibody Technique, Indirect; Glial Fibrillary Acidic Protein; Glucocorticoids; Injections; Macular Edema; Membrane Proteins; Occludin; Ophthalmoscopy; Retinal Vein Occlusion; Swine; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2009 |
Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Humans; Intraocular Pressure; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity | 2009 |
Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2008 |
Changes of aqueous vascular endothelial growth factor and interleukin-6 after intravitreal triamcinolone for branch retinal vein occlusion.
Topics: Aged; Aqueous Humor; Female; Fluorescein Angiography; Glucocorticoids; Humans; Hypertension; Interleukin-6; Macula Lutea; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2008 |
Bilateral simultaneous intravitreal injections in the office setting.
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Dexamethasone; Diabetic Retinopathy; Drug Therapy, Combination; Functional Laterality; Humans; Injections; Intraoperative Complications; Macular Degeneration; Macular Edema; Office Visits; Postoperative Complications; Ranibizumab; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2009 |
A case of herpetic epithelial keratitis after triamcinolone acetonide subtenon injection.
Topics: Acyclovir; Aged; Antiviral Agents; Epithelium, Corneal; Fascia; Female; Glucocorticoids; Herpesvirus 1, Human; Humans; Injections; Keratitis, Herpetic; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide; Virus Activation | 2009 |
Secondary macular hole associated with central retinal vein occlusion treated with corticosteroid injection.
Topics: Aged; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Recurrence; Retinal Perforations; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitrectomy | 2009 |
Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Fluorescein Angiography; Glaucoma, Angle-Closure; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris; Neovascularization, Pathologic; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity | 2010 |
Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to central retinal vein occlusion--a matched-pairs analysis.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Matched-Pair Analysis; Middle Aged; Retina; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2010 |
SCOREing in retinal venous occlusive disease.
Topics: Clinical Trials as Topic; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Prospective Studies; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2009 |
Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity | 2009 |
Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections; Male; Prognosis; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2009 |
Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intraocular; Kaplan-Meier Estimate; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Secondary Prevention; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Connective Tissue; Decompression, Surgical; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Prospective Studies; Regional Blood Flow; Retinal Artery; Retinal Neovascularization; Retinal Vein; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2010 |
Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Glucocorticoids; Humans; Injections; Prognosis; Retinal Vein Occlusion; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chi-Square Distribution; Humans; Intravitreal Injections; Macular Edema; Retinal Vein Occlusion; Tonometry, Ocular; Triamcinolone Acetonide | 2010 |
Response to: Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion by Schroff et al..
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Glucocorticoids; Humans; Intravitreal Injections; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2011 |
Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Male; Matched-Pair Analysis; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Aqueous Humor; Chemokine CCL2; Chemokine CCL4; Chemokines; Female; Fovea Centralis; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide | 2012 |
Simultaneous intravitreal injection of triamcinolone acetonide and tissue plasminogen activator for central retinal vein occlusion: a pilot study.
Topics: Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Tissue Plasminogen Activator; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2011 |
Bevacizumab and triamcinolone for branch vein occlusion.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2010 |
Intravitreal triamcinolone acetonide induced changes in the anterior segment in a pig model of branch retinal vein occlusion.
Topics: Animals; Anterior Eye Segment; Ciliary Body; Cytoskeletal Proteins; Disease Models, Animal; Eye Proteins; Fluorescent Antibody Technique, Indirect; Glucocorticoids; Glycoproteins; Intraocular Pressure; Intravitreal Injections; Iris; Retinal Vein Occlusion; Swine; Trabecular Meshwork; Triamcinolone Acetonide | 2011 |
Secondary ocular hypertension after intravitreal injection with 2 mg or 4 mg of triamcinolone in retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Tonometry, Ocular; Trabeculectomy; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2010 |
Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion.
Topics: Aged; Female; Fixation, Ocular; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests; Visual Fields; Vitreous Body | 2010 |
Combined arteriovenous sheathotomy and intraoperative intravitreal triamcinolone acetonide for branch retinal vein occlusion.
Topics: Administration, Intravesical; Adult; Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2010 |
Association between integrity of foveal photoreceptor layer and visual outcome in retinal vein occlusion.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Photoreceptor Cell Inner Segment; Retinal Photoreceptor Cell Outer Segment; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Differential effects of triamcinolone and bevacizumab in central retinal vein occlusion.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Hemorrhage; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Effects of intravitreal triamcinolone acetonide on retinal gene expression in a rat model of central retinal vein occlusion.
Topics: Animals; Cytokines; Disease Models, Animal; Gene Expression Regulation; Glucocorticoids; Intercellular Signaling Peptides and Proteins; Intravitreal Injections; Ion Channels; Macular Edema; Rats; Rats, Inbred BN; Retina; Retinal Pigment Epithelium; Retinal Vein Occlusion; Reverse Transcriptase Polymerase Chain Reaction; Triamcinolone Acetonide | 2011 |
[Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Topics: Aged; Anti-Inflammatory Agents; Diagnostic Techniques, Ophthalmological; Female; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Ophthalmoscopy; Retinal Vein Occlusion; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2011 |
Suprachoroidal drug infusion for the treatment of severe subfoveal hard exudates.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Catheterization; Diabetic Retinopathy; Exudates and Transudates; Feasibility Studies; Female; Follow-Up Studies; Humans; Macular Edema; Male; Microsurgery; Middle Aged; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity | 2012 |
Microperimetry as a routine diagnostic test in the follow-up of retinal vein occlusion?
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diagnostic Tests, Routine; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Male; Prospective Studies; Retinal Vein Occlusion; Scotoma; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Visual Field Tests; Visual Fields | 2012 |
[Complications of intravitreal injections--own experience].
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Conjunctival Diseases; Diabetic Retinopathy; Endophthalmitis; Eye Diseases; Eye Hemorrhage; Female; Follow-Up Studies; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Iris Diseases; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Poland; Ranibizumab; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Visual Acuity | 2011 |
[Prognosis for branch retinal vein occlusion].
Topics: Aged; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Humans; Light Coagulation; Male; Middle Aged; Prognosis; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2011 |
Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
Topics: Aged; Aged, 80 and over; Anesthetics, Local; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Diabetic Retinopathy; Endophthalmitis; Female; Fluoroquinolones; Glucocorticoids; Humans; Incidence; Intravitreal Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion.
Topics: Aged; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Prospective Studies; Recurrence; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests; Visual Fields | 2012 |
Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology.
Topics: Aged; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Prospective Studies; Retinal Detachment; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2012 |
[Role of intravitreal bevacizumab for resistant macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Treatment Failure; Triamcinolone Acetonide | 2012 |
Different dosages of intravitreal triamcinolone acetonide injections for macular edema secondary to central retinal vein occlusion.
Topics: Aged; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2012 |
Changes of inflammatory factors after intravitreal triamcinolone acetonide for macular edema with central retinal vein occlusion.
Topics: Aged; Aqueous Humor; Eye Proteins; Female; Glucocorticoids; Humans; Inflammation; Intercellular Adhesion Molecule-1; Intravitreal Injections; Macular Edema; Male; Nerve Growth Factors; Retinal Vein Occlusion; Serpins; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2013 |
Triamcinolone intravitreal injection and intraocular pressure in macular edema associated with retinal vein occlusion.
Topics: Aged; Anti-Inflammatory Agents; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Tonometry, Ocular; Triamcinolone Acetonide | 2012 |
Posterior vitreous detachment following intravitreal drug injection.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Fourier Analysis; Humans; Incidence; Intravitreal Injections; Macular Edema; Male; Microscopy, Acoustic; Middle Aged; Prospective Studies; Ranibizumab; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitreous Detachment; Wet Macular Degeneration | 2013 |
Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion.
Topics: Aged; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2002 |
Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
Topics: Aged; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2002 |
Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults.
Topics: Adult; Combined Modality Therapy; Fluorescein Angiography; Glucocorticoids; Humans; Male; Ophthalmologic Surgical Procedures; Retinal Vein; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity | 2003 |
Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
Topics: Aged; Anti-Inflammatory Agents; Female; Fluorescein Angiography; Humans; Injections; Interferometry; Macular Edema; Male; Retinal Vein Occlusion; Tomography; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Noninfectious endophthalmitis associated with intravitreal triamcinolone injection.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Endophthalmitis; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Pseudophakia; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Interferometry; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
Topics: Aged; Anti-Inflammatory Agents; Female; Fluorescein Angiography; Humans; Injections; Interferometry; Macular Edema; Male; Retinal Vein Occlusion; Tomography; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study.
Topics: Aged; Edema; Female; Fundus Oculi; Glucocorticoids; Humans; Injections; Macula Lutea; Male; Middle Aged; Retinal Diseases; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion.
Topics: Adult; Glucocorticoids; Humans; Macular Edema; Male; Retinal Vein Occlusion; Triamcinolone Acetonide | 2004 |
Intraocular availability of triamcinolone acetonide after intravitreal injection.
Topics: Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Female; Gas Chromatography-Mass Spectrometry; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2004 |
Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Topics: Glucocorticoids; Humans; Macular Edema; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Topics: Glucocorticoids; Humans; Injections; Macular Edema; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide.
Topics: Aged; Case-Control Studies; Diabetic Retinopathy; Eye Diseases; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Retinal Detachment; Retinal Vein Occlusion; Staining and Labeling; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2004 |
Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion.
Topics: Adult; Aged; Child; Female; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2004 |
Orbital abscess following subtenon triamcinolone injection.
Topics: Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clindamycin; Drainage; Eye Infections, Bacterial; Fascia; Female; Glucocorticoids; Humans; Injections; Macular Edema; Orbital Diseases; Retinal Vein Occlusion; Staphylococcal Infections; Staphylococcus aureus; Tomography, X-Ray Computed; Triamcinolone Acetonide | 2004 |
Intravitreal triamcinolone acetonide for the treatment of central retinal vein occlusion in young patients.
Topics: Adult; Female; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Injections; Male; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2004 |
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Recurrence; Retinal Vein Occlusion; Retrospective Studies; Safety; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion.
Topics: Aged; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema.
Topics: Anti-Inflammatory Agents; Follow-Up Studies; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Pilot Projects; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Trans-tenon retrobulbar triamcinolone infusion for chronic macular edema in central and branch retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Connective Tissue; Female; Glucocorticoids; Humans; Infusions, Parenteral; Macular Edema; Middle Aged; Orbit; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2004 |
Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials.
Topics: Clinical Trials as Topic; Diabetic Retinopathy; Glucocorticoids; Humans; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2005 |
Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Topics: Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreous triamcinolone simulating frosted retinal angiitis.
Topics: Aged; Diagnosis, Differential; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Retinal Vasculitis; Retinal Vein Occlusion; Retinal Vessels; Triamcinolone Acetonide; Vitreous Body | 2005 |
Submacular placoid pigment epithelial alteration after resolution of macular edema in central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Decompression, Surgical; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Optic Nerve; Pigment Epithelium of Eye; Postoperative Complications; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2005 |
Steroids for branch retinal vein occlusion.
Topics: Glucocorticoids; Humans; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide | 2005 |
Reply to intrevitreal triamcinolone for branch retinal vein occlusion.
Topics: Anti-Inflammatory Agents; Humans; Research Design; Retinal Vein Occlusion; Statistics as Topic; Triamcinolone Acetonide; Visual Acuity | 2006 |
Trans-tenon retrobulbar triamcinolone injection for macular edema associated with branch retinal vein occlusion remaining after vitrectomy.
Topics: Aged; Aged, 80 and over; Connective Tissue; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Orbit; Prospective Studies; Retinal Vein Occlusion; Safety; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2005 |
Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
Topics: Aged; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal versus retrobulbar injection of triamcinolone for young patients.
Topics: Adult; Age Factors; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Orbit; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
Retinal pigment epithelium (RPE) pigmentation and thickening in the central macula after macular edema resolution in central retinal vein occlusion (CRVO).
Topics: Combined Modality Therapy; Decompression, Surgical; Humans; Macula Lutea; Macular Edema; Pigment Epithelium of Eye; Postoperative Complications; Retinal Diseases; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide | 2006 |
Intravitreal triamcinolone for ischemic branch retinal vein occlusion with serous retinal detachment.
Topics: Aged, 80 and over; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Ischemia; Male; Retinal Detachment; Retinal Vein; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2006 |
Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
Topics: Diabetic Retinopathy; Endophthalmitis; Glucocorticoids; Humans; Incidence; Injections; Macular Degeneration; Macular Edema; Preservatives, Pharmaceutical; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
Topics: Aged; Endophthalmitis; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Retinal Necrosis Syndrome, Acute; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2006 |
Radial optic neurotomy with adjunctive intraocular triamcinolone for central retinal vein occlusion: 63 consecutive cases.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Decompression, Surgical; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Optic Disk; Optic Nerve; Postoperative Complications; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2006 |
Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Ischemia; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Retinal Vessels; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Retina; Retinal Artery Occlusion; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Retina; Retinal Artery Occlusion; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intractable glaucoma following posterior sub-tenon's triamcinolone acetonide for central retinal vein occlusion in a young adult.
Topics: Adult; Fundus Oculi; Glaucoma; Glucocorticoids; Humans; Male; Retinal Vein Occlusion; Trabeculectomy; Triamcinolone Acetonide | 2006 |
Ultrastructure of the trabecular meshwork in secondary glaucoma eyes after intravitreal triamcinolone acetonide.
Topics: Extracellular Matrix; Female; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Retinal Vein Occlusion; Trabecular Meshwork; Trabeculectomy; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2006 |
Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Ischemia; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
Topics: Drug Administration Schedule; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2007 |
Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Topics: Combined Modality Therapy; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Retinal Artery Occlusion; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide | 2006 |
[Intravitreal application of triamcinolone--our experiences].
Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion.
Topics: Adult; Aged; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Technique of administering the intravitreal injection, and the optimum dosage required to gain a therapeutic benefit.
Topics: Drug Administration Schedule; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2007 |
Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retinal Vein Occlusion; Statistics as Topic; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
Topics: Diabetic Retinopathy; Endophthalmitis; Glucocorticoids; Humans; Incidence; Injections; Macular Degeneration; Macular Edema; Preservatives, Pharmaceutical; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Phacoemulsification; Retinal Artery Occlusion; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Topics: Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Ischemia; Macular Edema; Retinal Vein Occlusion; Retinal Vessels; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Glaucoma, Open-Angle; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Trabeculectomy; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Deposition of triamcinolone crystals on the posterior lens capsule following prone posturing post-vitrectomy.
Topics: Crystallization; Female; Glucocorticoids; Humans; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Macular Edema; Middle Aged; Phacoemulsification; Postoperative Complications; Prone Position; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitrectomy | 2006 |
Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
Topics: Endophthalmitis; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Retinal Necrosis Syndrome, Acute; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2006 |
Intraocular triamcinolone acetonide for macular edema due to CRVO. A multifocal-ERG and OCT study.
Topics: Adult; Aged; Electroretinography; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Triamcinolone-assisted pars plana vitrectomy for retinal disease.
Topics: Diabetic Retinopathy; Epiretinal Membrane; Glucocorticoids; Humans; Macula Lutea; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Detachment | 2005 |
Filter connected with three-way cock in remove of the vehicle in triamcinolone acetonide.
Topics: Administration, Topical; Adult; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Retinal Diseases; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2006 |
[Macular oedema and intravitreal triamcinolone injections].
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Diabetic Retinopathy; Follow-Up Studies; Humans; Iceland; Injections; Macular Edema; Middle Aged; Phacoemulsification; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2006 |
Perimetric sensitivity with the micro perimeter 1 and retinal thickness in patients with branch retinal vein occlusion.
Topics: Aged; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Field Tests | 2007 |
Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Topics: Adult; Aged; Aged, 80 and over; Connective Tissue; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2007 |
A case of mycotic endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy.
Topics: Anti-Inflammatory Agents; Endophthalmitis; Female; Fundus Oculi; Fusarium; Humans; Injections; Intraoperative Care; Macular Edema; Middle Aged; Mycoses; Postoperative Care; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2007 |
Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
Topics: Aged; Diabetic Retinopathy; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2007 |
Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Connective Tissue; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide | 2007 |
Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow.
Topics: Aged; Blood Flow Velocity; Diabetic Retinopathy; Diastole; Eye; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Ophthalmic Artery; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Vascular Resistance; Vitreous Body | 2007 |
Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
Topics: Aged; Case-Control Studies; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2007 |
Intravitreal triamcinolone.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2007 |
[Inhtravitreal triamcinolone acetonide injections in the treatment of cystoid macular edema due to the central or branch retinal vein occlusion].
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Injections; Macular Edema; Male; Middle Aged; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2007 |
Efficacy of intravitreal triamcinolone for macular oedema due to CRVO after anti-androgen therapy for hirsutism in a young monocular female.
Topics: Adult; Androgen Antagonists; Female; Glucocorticoids; Hirsutism; Humans; Macular Edema; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide | 2007 |
Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Cataract; Disease Progression; Drug Evaluation; Female; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2008 |
Decreased retinal vein diameter after intravitreal triamcinolone for retinal vein occlusions.
Topics: Aged; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Middle Aged; Retinal Vein; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Two-year results of intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion.
Topics: Aged; Connective Tissue; Eye; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Postoperative Period; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Glucocorticoids; Gonioscopy; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2008 |
Intravitreal triamcinolone reduces the morphologic changes of ciliary body after pars plana vitrectomy for retinal vascular diseases.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Ciliary Body; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Male; Microscopy, Acoustic; Middle Aged; Postoperative Complications; Prospective Studies; Retinal Diseases; Retinal Vein Occlusion; Triamcinolone Acetonide; Uveal Diseases; Vitrectomy; Vitreous Body | 2008 |
Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.
Topics: Animals; Disease Models, Animal; Glucocorticoids; Injections; Male; Optic Disk; Retinal Neovascularization; Retinal Vein Occlusion; Swine; Triamcinolone Acetonide; Vitreous Body | 1996 |
Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide | 2002 |